Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Revive Therapeutics Ltd
C.RVV
Alternate Symbol(s):
RVVTF
Healthcare
Biotechnology
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro...
diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:RVV)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(145)
•••
CrazyProphet
X
Post by
CrazyProphet
on Jan 03, 2023 8:48am
Time to Rock n Roll
(27)
•••
cool888
X
Post by
cool888
on Dec 31, 2022 9:57pm
Happy New Year Revive Family ! Best Wishes to ALL !!
(27)
•••
cool888
X
Post by
cool888
on Dec 31, 2022 10:19am
CDC tracking rise of new XBB.1.5 COVID variant !
#Bucillamine https://www.cbsnews.com/news/covid-variant-xbb-1-5-cdc-tracking-us-cases/?ftag=CNM-00-10aab8d&linkId=195514720
(145)
•••
CrazyProphet
X
Post by
CrazyProphet
on Dec 31, 2022 9:42am
Nothing but up 😽👀⬆️
https://twitter.com/StoicAdvisory/status/1608963533454336000?s=20&t=RyleuehFbtgQ32aL8haYIg https://twitter.com/CharlieMunger00/status/1608965674109636608?s=20&t=RyleuehFbtgQ32aL8haYIg
(27)
•••
cool888
X
Post by
cool888
on Dec 30, 2022 7:29pm
FDA broke own protocols in approving Biogen Alzheimer’s drug
https://www.nbcnews.com/health/health-news/fda-broke-protocols-approving-biogen-alzheimers-drug-congressional-rep-rcna63662
(27)
•••
cool888
X
Post by
cool888
on Dec 30, 2022 6:23am
China Approves Merck’s Covid Antiviral Amid Shortage of Drug
#Bucillamine https://www.bnnbloomberg.ca/china-approves-merck-s-covid-antiviral-amid-shortage-of-drugs-1.1864364
(12)
•••
DehydraTECH
X
Post by
DehydraTECH
on Dec 23, 2022 5:18pm
Only 25 million cap EDSA
FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate 2022-12-20 08:31 ET - News Release Fast Track improves the speed and frequency of communication with
...more
(7)
•••
90guppy
X
Comment by
90guppy
on Dec 23, 2022 9:03am
RE:China COVID deaths probably running above 5,000 per day !
FO-OL aka COOL, we know the science, we know what bucillamine can bring, its the mgt that u should call out for them to do the job.
(27)
•••
cool888
X
Post by
cool888
on Dec 22, 2022 8:29pm
U.S. FDA approves Roche's COVID-19 antibody !
#Bucillamine https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-roches-covid-19-antibody-2022-12-21/?utm_source=reddit.com
(27)
•••
cool888
X
Post by
cool888
on Dec 22, 2022 5:20pm
China COVID deaths probably running above 5,000 per day !
#Bucillamine https://www.reuters.com/world/china/china-covid-deaths-probably-running-above-5000-per-day-uk-research-firm-2022-12-22/
(27)
•••
cool888
X
Post by
cool888
on Dec 22, 2022 2:26pm
$RVV Update !
#Bucillamine https://finance.yahoo.com/news/revive-therapeutics-announces-submission-type-190000761.html
(0)
•••
PressRelease
X
Post by
PressRelease
on Dec 22, 2022 2:01pm
New Press Release - Revive Therapeutics Announces Submission of Type C Meeting Request to FDA for Amended Protocol Agreement of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19
TORONTO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has...
read article.
(7)
•••
90guppy
X
Comment by
90guppy
on Dec 21, 2022 12:48pm
RE:RE:Revive Therapeutics Ltd. Expands Life Offering to Quebec
HAHAHA, LOL, fullofshit
(7)
•••
90guppy
X
Comment by
90guppy
on Dec 19, 2022 4:37pm
RE:Revive Therapeutics Ltd. Expands Life Offering to Quebec
HAHAHA, strings, full of G-strings
(7)
•••
90guppy
X
Comment by
90guppy
on Dec 15, 2022 1:37pm
RE:RE:Revive Therapeutics Ltd. Expands Life Offering to Quebec
blah blah blah blah, oh the string, give us more string!
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
SALT: quietly powering industries, keeping roads safe, and even shaping the global economy
The first public copper company permitted to drill in Argentina’s newly opened Mendoza province
Allied Critical Metals Confirms Ultra High-Grade Tungsten Zone at Borralha
Pinnacle Extends Gold-Silver Mineralized Horizon to Almost 500 Metres at Historic La Dura Mine